BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Announce Completion of Merger
10/14/2009 11:35:06 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) And Cell Genesys, Inc. (CEGE) Announce Approval of Merger by BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 14, 2009
10/1/2009 10:44:21 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Announce Final Exchange Ratio for Merger
9/23/2009 8:56:01 AM
More...
|
RiskMetrics – ISS Governance Services Recommends Stockholders Vote “FOR” BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Merger
9/17/2009 9:21:15 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Announce September 30, 2009 Special Stockholders Meetings to Approve Merger
9/3/2009 9:55:36 AM
More...
|
Cell Genesys, Inc. (CEGE) Announces Second Quarter 2009 Financial Results
8/5/2009 9:49:15 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) to Buy Cell Genesys, Inc. (CEGE) for $38 Million
6/30/2009 7:54:27 AM
More...
|
Cell Genesys, Inc. (CEGE) Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives
6/23/2009 9:42:37 AM
More...
|
Cell Genesys, Inc. (CEGE) Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives; Company’s Staff Down to 9
6/23/2009 7:33:52 AM
More...
|
Cell Genesys, Inc. (CEGE) Commences Exchange Offer for $68.3 million Convertible Notes
5/26/2009 9:17:07 AM
More...
|
|